Abstract
Germline mutations in either of the two major breast cancer predisposition genes, BRCA1 and BRCA2, account for a significant proportion of hereditary breast/ovarian cancer. Identification of breast cancer patients carrying mutations of these genes is primarily based on a positive family history of breast/ovarian cancer or early onset of the disease or both. In the course of mutation screening of the BRCA1 and BRCA2 genes in a hospital based series of patients with risk factors for hereditary breast/ovarian cancer, we identified a germline mutation in the BRCA2 gene (3034del4) in a patient with early onset breast cancer and no strong family history of the disease. Subsequent molecular analysis in her parents showed that neither of them carried the mutation. Paternity was confirmed using a set of highly polymorphic markers, showing that the proband carried a de novo germline mutation in the BRCA2 gene. Interestingly, 3034del4 is a recurrent mutation occurring in a putative mutation prone region of the BRCA2 gene. Our study presents the first case in which a de novo germline mutation in the BRCA2 gene has been identified, and supports previous results of haplotype studies, confirming that the 3034del4 mutation has multiple independent origins. Keywords: breast cancer; BRCA2 gene; de novo mutation
Full Text
The Full Text of this article is available as a PDF (150.1 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Antonarakis S. E. Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group. Hum Mutat. 1998;11(1):1–3. doi: 10.1002/(SICI)1098-1004(1998)11:1<1::AID-HUMU1>3.0.CO;2-O. [DOI] [PubMed] [Google Scholar]
- Epstein C. J. 1996 ASHG Presidential Address. Toward the 21st century. Am J Hum Genet. 1997 Jan;60(1):1–9. [PMC free article] [PubMed] [Google Scholar]
- Hogervorst F. B., Cornelis R. S., Bout M., van Vliet M., Oosterwijk J. C., Olmer R., Bakker B., Klijn J. G., Vasen H. F., Meijers-Heijboer H. Rapid detection of BRCA1 mutations by the protein truncation test. Nat Genet. 1995 Jun;10(2):208–212. doi: 10.1038/ng0695-208. [DOI] [PubMed] [Google Scholar]
- Ligtenberg M. J., Hogervorst F. B., Willems H. W., Arts P. J., Brink G., Hageman S., Bosgoed E. A., Van der Looij E., Rookus M. A., Devilee P. Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2. Br J Cancer. 1999 Mar;79(9-10):1475–1478. doi: 10.1038/sj.bjc.6690235. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Meijers-Heijboer E. J., Verhoog L. C., Brekelmans C. T., Seynaeve C., Tilanus-Linthorst M. M., Wagner A., Dukel L., Devilee P., van den Ouweland A. M., van Geel A. N. Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation. Lancet. 2000 Jun 10;355(9220):2015–2020. doi: 10.1016/s0140-6736(00)02347-3. [DOI] [PubMed] [Google Scholar]
- Miki Y., Swensen J., Shattuck-Eidens D., Futreal P. A., Harshman K., Tavtigian S., Liu Q., Cochran C., Bennett L. M., Ding W. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994 Oct 7;266(5182):66–71. doi: 10.1126/science.7545954. [DOI] [PubMed] [Google Scholar]
- Neuhausen S. L., Godwin A. K., Gershoni-Baruch R., Schubert E., Garber J., Stoppa-Lyonnet D., Olah E., Csokay B., Serova O., Lalloo F. Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study. Am J Hum Genet. 1998 Jun;62(6):1381–1388. doi: 10.1086/301885. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Neuhausen S. L., Mazoyer S., Friedman L., Stratton M., Offit K., Caligo A., Tomlinson G., Cannon-Albright L., Bishop T., Kelsell D. Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study. Am J Hum Genet. 1996 Feb;58(2):271–280. [PMC free article] [PubMed] [Google Scholar]
- Tesoriero A., Andersen C., Southey M., Somers G., McKay M., Armes J., McCredie M., Giles G., Hopper J. L., Venter D. De novo BRCA1 mutation in a patient with breast cancer and an inherited BRCA2 mutation. Am J Hum Genet. 1999 Aug;65(2):567–569. doi: 10.1086/302503. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wooster R., Bignell G., Lancaster J., Swift S., Seal S., Mangion J., Collins N., Gregory S., Gumbs C., Micklem G. Identification of the breast cancer susceptibility gene BRCA2. Nature. 1995 Dec 21;378(6559):789–792. doi: 10.1038/378789a0. [DOI] [PubMed] [Google Scholar]